ROR1 and CD137 modulator therapy(Crescendo Biologics)

N/A

Report date: 2024/04/19 15:02:40

Base Information

Drug NameROR1 and CD137 modulator therapy(Crescendo Biologics)

Drug Alias NameN/A

ClassificationBiologics

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 modulatorsTumor necrosis factor receptor superfamily member 9 modulators

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCrescendo Biologics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCrescendo Biologics Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A